GS1 Connect – Bridging the Gap

Join Jeff Denton (AmerisourceBergen) and Gary Lerner (Gateway Checker) as they discuss how to bridge the gap to US Drug traceability at the GS1 Connect Digital Conference, June 16 and 17.

GS1 Connect: Bridging the Gap to Pharmaceutical Traceability

FDA regulations mandates interoperable, electronic tracing of medicines at the item level to enhance the security of the US Drug supply chain by 2023.

Establishing traceability requires accurate and complete data sharing among trading partner within the drug supply network.

Closing the gap to traceability is essential for major US pharmaceutical wholesalers. See the challenges AmerisourceBergen faces as they prepare to onboard more than 500 drug manufacturers and accept serialized electronic transactions from nearly 25,000 drugs   Learn how they utilize new tools and technology from Gateway Checker to test, evaluate and certify conformance to GS1 US traceability standards.

Conformance to the GS1 Electronic Product Code Information Services (EPCIS) standards specific to the Drug Supply Chain Security Act allows trading partners within the supply chain to enable compatible connections: first-time, every-time.

Register for complimentary attendance to the GS1 Connect Digital conference.

Gateway Checker’s Gary Lerner to Discuss Pharmaceutical Traceability at GS1 Connect

Gary Lerner, president and founder of Gateway Checker and expert on supply chain integrity, will be discussing the future of pharmaceutical traceability at the GS1 Connect virtual conference, taking place June 16-17, 2020. Gary, together with Jeff Denton of AmerisourceBergen, will present “Bridging the Gap to Pharmaceutical Traceability” as an On Demand session, which will be available throughout the two-day event.

During their session, Gary and Jeff will explore how the drug industry as a whole is adjusting to the requirements outlined in the Drug Supply Security Act of 2013 and what companies can do today to prepare for the new traceability standards that will be required by 2023. These requirements aim to help the FDA understand what product is in the supply chain, where it has been, where it is going, and who is handling it; and to ensure that only legitimate, safe products end up on the market.

Currently, much of the data collected along the drug supply chain is either inadequate or not interoperable according to accepted industry guidelines. Many organizations have developed their own proprietary solutions or workarounds that don’t play well together. Gary will address how agreeing upon and employing a “common language” across the pharmaceutical industry is vital in preparing for the upcoming regulations and requirements.

FREE Registration for GS1 Connect is open through Friday, June 12 at

About Gateway Checker

Gateway Checker provides software to help the pharmaceutical industry quickly, accurately and thoroughly ensure data accuracy and integrity about the products moving through the drug supply chain. Gateway Checker is a GS1 Certified Conformance Testing Service, and can attest to full conformance with the GS1 US Rx EPCIS traceability requirements.

About GS1 Connect

GS1 Connect is an annual event hosted by GS1 US for the purpose of bringing trading partners together to network and learn about the value of using standards-based business processes and best practices for optimum efficiencies in managing the supply and demand sides of their value chain. Due to COVID-19, this year’s event will be virtual.

Sign Up Now for GS1!